Breaking News

Goodwin Names COO

By Gil Roth | September 16, 2013

Lee rejoins bio-CMO

SooYoung Lee, Ph.D. has returned to Goodwin Biotechnology as chief operating officer. Dr. Lee will report to the newly appointed chief executive officer, Karl Pinto, and will oversee all aspects of Goodwin's contract manufacturing operations. He previously served at Goodwin as senior vice president, operations from 2010 to 2011.

Dr. Lee has had a multi-decade career in the biological industry. He has held several leadership positions at such biopharma companies and CMOs as SAIC – Frederick, Schering-Plough Research Institute, Wyeth – Lederle Vaccines, AppTec, Neose Technologies and Genencor. He also has extensive experience in international biotechnology operations, having established and served as the director of the Biopharmaceutical Manufacturing Technology Center (BMTC) in Singapore. As a senior member, he helped establish the International Vaccine Institute (IVI) in Seoul, Korea.

"SooYoung's experiences in process development, tech transfer and GMP manufacturing along with strategic planning and execution will help ensure the delivery of the highest quality services and products that are in compliance with cGMP to our clients, ranging from the smallest biotech start-ups to large biopharma companies," noted Mr. Pinto. "With this significant addition, we are poised to take the company to new heights."

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important